Atrial Fibrillation Clinical Trials

Find Atrial Fibrillation Clinical Trials Near You

Anthocyanin-Rich Table Grape Powder for Prophylaxis of Post-Operative Atrial Fibrillation

Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 1/Phase 2
SUMMARY

Postoperative atrial fibrillation (POAF) is a common complication following cardiac surgery and leads to worse outcomes. POAF is thought to be caused by the inflammatory state following cardiac surgery. It may be that anti-inflammatory medications could lower the occurrence of POAF, however many typical anti-inflammatory medications, such as ibuprofen, are contraindicated in the post cardiac surgery patient due to increased risks of bleeding. If a drug was identified with anti-inflammatory properties with minimal deleterious side effects, this could be broadly applied to cardiac surgery patients for the prevention of POAF. Interestingly, several small trials have shown that medications that alter transcription of inflammatory markers lead to decreased POAF. Furthermore, we have shown that phytochemicals, such as those found in grapes, have excellent bioavailability and can affect cardiac gene transcription related to inflammation. In this study, we propose to evaluate the efficacy of preoperative administration of concentrated grape powder in the prevention of POAF.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 79
Healthy Volunteers: f
View:

• Males and female patients (age 50-79) at the Mitral Valve Clinic/CVC undergoing elective cardiac surgery for mitral valve repair without the Cox MAZE procedure (MVR patients also undergoing CABG and/or tricuspid valve repair are also eligible)

• In sinus rhythm (no pre-operative atrial fibrillation)

Locations
United States
Michigan
University of Michigan - Michigan Medicine
RECRUITING
Ann Arbor
Contact Information
Primary
China Green, BS
chjgreen@med.umich.edu
734-936-7731
Time Frame
Start Date: 2026-04
Estimated Completion Date: 2027-08
Participants
Target number of participants: 70
Treatments
Experimental: Concentrated grape powder
Placebo_comparator: Placebo
Related Therapeutic Areas
Sponsors
Leads: University of Michigan
Collaborators: California Table Grape Commission

This content was sourced from clinicaltrials.gov